EARTH SCIENCE PHARMACEUTICAL, INC
DORAL, FLORIDA

The Executive Team of Earth Science Pharma, Inc. boasts years of scientific, medical, and business experience in the health, research, and manufacturing fields. President, Director, & COO Mr Nickolas Tabraue is an industry veteran having nine years of professional experience in the nutraceutical and dietary supplement fields, as well as retail corporate management. Mr Tabraue brings to the company his skills and knowledge of supplements, retail management, and customer service. His management experience at The Vitamin Shoppe encompassed the management of four different locations, one being the company’s highest volume and another including the restructuring of a non-performing high volume store to achieve high operating levels in operations, service, inventory compliance, and sales. Laurent Azoulay, Ph.D., has joined both the Cannabis Therapeutics and Earth Science Pharmaceutical Advisory Boards. He is an Associate Professor of Oncology at McGill University, where he actively researches cancer pharmacoepidemiology, which includes evaluating the safety of cancer drugs at a societal level. After receiving his PhD in 2007 from the Université de Montréal, he completed a postdoctoral fellowship in pharmacoepidemiology at the Department of Epidemiology, Biostatistics and Occupational Health, McGill University. He then joined the Gerald Department of Oncology as an Assistant Professor in 2009. In 2016, he was promoted to the rank of Associate Professor with a cross-appointment with the Department of Epidemiology, Biostatistics and Occupational Health. Chandra Panchal, Ph.D., has joined the Cannabis Therapeutics, Earth Science Pharmaceutical, and Earth Science Tech Advisory Boards. He is a serial entrepreneur with a wealth of expertise acquired over 28 years of experience in the biotech/pharmaceutical sector. Dr. Panchal founded Axcelon in 2001 and was a co-founder of Procyon Biopharma Inc., a publicly traded biotechnology company involved in the development of wound healing, cancer therapeutic, and diagnostic products. Now known as Ambrilia BioPharma Inc., the company listed on the Alberta Stock Exchange in 1998 and the TSX in 2000. He served as Procyon Biopharma Inc.’s Chairman, President, and CEO; and Ambrilia Biopharma Inc.’s Senior Executive Vice-President, Business Development, Licensing, and Intellectual Property in charge of out-licensing, in-licensing and M&A activities. He retired from Ambrilia Biopharma Inc. in February 2008. Since then, Dr. Panchal has been actively involved in Axcelon. Prior to founding Procyon Biopharma Inc., Dr. Panchal was a senior scientist/group leader supervising activities related to yeast genetics, fermentations, and product development at John Labatt Ltd., a multinational food and beverage company. Dr. Panchal sits on the board of directors of several public and private companies. He has authored/co-authored over 60 scientific papers and has edited a book entitled Yeast Strain Selection. Dr. Panchal has been an Adjunct Professor at the University of Western Ontario where he obtained his Ph.D. in biochemical engineering. Earth Science Pharma is an emerging medical research company that is dedicated to developing leading-edge medical devices and vaccines that will improve the health and particularly for women around the world. The issue of women’s health and access to health is a global problem that has enormous social and economic ramifications for developing and developed countries. The key to supporting and improving the health of women is to create new medical devices that give women more control over their health, and vaccines and other prophylactic treatments to help women avoid diseases.